Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials
Title |
Intervention | NCT ID | Sponsor | Status |
|---|---|---|---|---|
| 4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast... | oral placebo, afimoxifene, tamoxifen citrate, placebo gel | NCT00952731 | Northwestern University | Completed |
| Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer | Aspirin, Eflornithine, Laboratory Biomarker Analysis, Placebo, Telephone-Based Intervention | NCT00983580 | National Cancer Institute (NCI) | Active, not recruiting |
| Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules | Aspirin, Laboratory Biomarker Analysis, Placebo | NCT02169271 | National Cancer Institute (NCI) | Active, not recruiting |
| Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer | acolbifene hydrochloride | NCT00853996 | University of Kansas Medical Center | Completed |
| ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing... | Laboratory Biomarker Analysis, Metformide Hydrochloride/Pioglitazone Hydrochloride Extended-Release Tablet, Pharmacological Study, Placebo | NCT02917629 | National Cancer Institute (NCI) | Recruiting |
| Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast | Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration | NCT03063619 | M.D. Anderson Cancer Center | Recruiting |
| Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II... | Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery | NCT02598557 | National Cancer Institute (NCI) | Recruiting |
| A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer | atorvastatin calcium, laboratory biomarker analysis | NCT00637481 | National Cancer Institute (NCI) | Completed |
| Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers | Aspirin, Laboratory Biomarker Analysis, Placebo, Zileuton | NCT02348203 | National Cancer Institute (NCI) | Active, not recruiting |
| Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer | acetylsalicylic acid, placebo, laboratory biomarker analysis | NCT00468910 | National Cancer Institute (NCI) | Completed |